Latest & greatest articles for amphetamine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amphetamine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amphetamine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amphetamine

1. Amphetamines probably the best first-choice treatment for adults with ADHD

Amphetamines probably the best first-choice treatment for adults with ADHD Amphetamines probably the best first-choice treatment for adults with ADHD Dissemination Centre Discover Portal NIHR DC Discover Amphetamines probably the best first-choice treatment for adults with ADHD Published on 30 October 2018 doi: There is further evidence to support the amphetamines as the most effective group of drugs for treating adults with attention deficit hyperactivity disorder in the short-term. Two (...) of these drugs were shown to provide the most improvement in core symptoms of attention deficit hyperactivity disorder, are tolerated as well as any other drug treatment and are less likely to be stopped. The review did not identify data to determine whether amphetamines should continue to be used for longer than 12 weeks. This large, comprehensive NIHR-funded systematic review included published and unpublished randomised controlled trials of different drug treatments. The quality of the included trials

NIHR Dissemination Centre2018

2. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is a childhood-onset disorder characterised by inattention, hyperactivity, and impulsivity. ADHD can persist into adulthood and can affects individuals' social and occupational functioning, as well as their quality of life and health. ADHD is frequently associated with other mental disorders such as substance use disorders and anxiety and affective disorders (...) . Amphetamines are used to treat adults with ADHD, but uncertainties about their efficacy and safety remain. OBJECTIVES: To examine the efficacy and safety of amphetamines for adults with ADHD. SEARCH METHODS: In August 2017, we searched CENTRAL, MEDLINE, Embase, PsycINFO, 10 other databases, and two trials registers, and we ran citation searches for included studies. We also contacted the corresponding authors of all included studies, other experts in the field, and the pharmaceutical company, Shire, and we

Cochrane2018

3. Amphetamine

Amphetamine Top results for amphetamine - Trip Database or use your Google+ account Turning Research Into Practice My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box (...) and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for amphetamine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical

Trip Latest and Greatest2018

5. The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis

The Use of Amphetamines for Improving Cognitive Impairment in Patients with Multiple Sclerosis "The Use of Amphetamines for Improving Cognitive Impairment in Patients" by Hayley Kum < > > > > > Title Author Date of Award Summer 8-13-2016 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Elizabeth Crawford, PA-C, MS Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: Multiple sclerosis (MS) is an autoimmune disorder (...) that results in debilitating cognitive impairment in 40-65% of patients. There are no current treatments for this symptom of MS. This is a systematic review of literature on the impact amphetamines have on cognitive function of MS patients. Methods: An exhaustive search of available medical literature was conducted using MEDLINE-Ovid, MEDLINE-PubMed, Web of Science, and CINAHL. Keywords used included: amphetamines and multiple sclerosis. Relevant articles were assessed for quality using GRADE. Results

Pacific University EBM Capstone Project2016

6. No evidence of benefit of psychostimulants for amphetamine abuse or dependence

No evidence of benefit of psychostimulants for amphetamine abuse or dependence No evidence of benefit of psychostimulants for amphetamine abuse or dependence | Cochrane Primary Care Top menu Trusted evidence. Informed decisions. Better health. Enter terms No evidence of benefit of psychostimulants for amphetamine abuse or dependence Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2017 The Cochrane Collaboration | |

Cochrane PEARLS2014

8. Treatment for amphetamine psychosis.

Treatment for amphetamine psychosis. BACKGROUND: Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis. OBJECTIVES: To evaluate risks, benefits, costs of treatments for amphetamine psychosis. SEARCH STRATEGY: MEDLINE (1966-2007), EMBASE (1980-2007), CINAHL (1982-2007), PsychINFO (1806-2007), CENTRAL (Cochrane (...) Library 2008 issue 1), references of obtained articles. SELECTION CRITERIA: All randomised controlled and clinical trials (RCTs, CCTs) evaluating treatments (alone or combined) for people with amphetamine psychosis DATA COLLECTION AND ANALYSIS: Two authors evaluated and extracted the data independently. Dichotomous data were extracted on an intention-to-treat basis in which the dropouts were assigned as participants with the worst outcomes. The Relative Risk (RR) with the 95% confidence interval (95

Cochrane2009

9. Speeding stroke recovery: a systematic review of amphetamine after stroke

Speeding stroke recovery: a systematic review of amphetamine after stroke Speeding stroke recovery: a systematic review of amphetamine after stroke Speeding stroke recovery: a systematic review of amphetamine after stroke Sprigg N, Bath PM CRD summary The authors concluded that use of amphetamines did not improve recovery after stroke and there were doubts about its safety. Although the review contained some flaws, the authors' conclusions reflected the data presented and are likely (...) to be reliable. Authors' objectives To evaluate the effectiveness of amphetamine to enhance stroke recovery. Searching Cochrane Stroke Group Trials Register, Cochrane Controlled Trials Register, MEDLINE, EMBASE and Science Citation Index were searched; search dates ranged from 1966 to June 2008. Search terms were reported. Bibliographies of retrieved articles and reviews were examined for further reports. Language restrictions were not reported. Study selection Randomised controlled trials (RCTs

DARE.2009

10. Review: limited evidence to support pharmacological therapy for amphetamine withdrawal

Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Review: limited evidence to support pharmacological therapy for amphetamine withdrawal | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword (...) Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Article Text Therapeutics Review: limited evidence to support pharmacological therapy for amphetamine withdrawal Free Michael Gossop Statistics from Altmetric.com No Altmetric data available for this article. Question Question

Evidence-Based Mental Health2009

11. Treatment for amphetamine psychosis.

Treatment for amphetamine psychosis. BACKGROUND: Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis. OBJECTIVES: To evaluate risks, benefits, costs of treatments for amphetamine psychosis. SEARCH STRATEGY: MEDLINE (1966-2007), EMBASE (1980-2007), CINAHL (1982-2007), PsychINFO (1806-2007), CENTRAL (Cochrane (...) Library 2008 issue 1), references of obtained articles. SELECTION CRITERIA: All randomised controlled and clinical trials (RCTs, CCTs) evaluating treatments (alone or combined) for people with amphetamine psychosis DATA COLLECTION AND ANALYSIS: Two authors evaluated and extracted the data independently. Dichotomous data were extracted on an intention-to-treat basis in which the dropouts were assigned as participants with the worst outcomes. The Relative Risk (RR) with the 95% confidence interval (95

Cochrane2008

12. What is the risk of AMI in amphetamine induced chest pain presenting to the ED?

What is the risk of AMI in amphetamine induced chest pain presenting to the ED? BestBets: What is the risk of AMI in amphetamine induced chest pain presenting to the ED? What is the risk of AMI in amphetamine induced chest pain presenting to the ED? Report By: Dr Bhavesh Papadi - SHO Medicine Search checked by Dr Karthikeyan Perumal - Radiation oncologist Institution: Chase Farm Hospital Date Submitted: 30th June 2007 Last Modified: 14th August 2008 Status: Green (complete) Three Part Question (...) In [patients presenting with chest pain following amphetamine use] what [is the incidence] of [acute myocardial infarction]? Clinical Scenario You are working in a very busy Accident and Emergency Department and the Triage Nurse informs you that, a patient with "Amphetamine induced chest pain" has just arrived. you wonder , what his chances are, to develop Acute Myocardial Infarction. Search Strategy Ovid MEDLINE(R) 1950 to March Week 2 2008 [exp Amphetamine-Related Disorders/or exp Amphetamine

BestBETS2008

14. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders.

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. BACKGROUND: The consumption of psychostimulants for non-medical reasons probably occurs because of their euphoriant and psychomotor-stimulating properties. Chronic consumption of these agents results in development of stereotyped behaviour, paranoia, and possibly aggressive behaviour. Psychosocial treatments for psychostimulant use disorder are supposed to improve compliance, and to promote abstinence

Cochrane2007

15. Amphetamines for improving recovery after stroke.

Amphetamines for improving recovery after stroke. BACKGROUND: Animal research shows that treatment with amphetamines improves recovery after focal cerebral ischaemia. If the effects are similar in humans, amphetamine treatment could have a major impact on recovery from stroke. OBJECTIVES: To assess the effects of amphetamine treatment in patients with stroke. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched January 2006), the Cochrane Central Register (...) of Controlled Trials (CENTRAL) (The Cochrane Library Issue 1, 2006), MEDLINE (1966 to January 2006), EMBASE (1980 to January 2006), CINAHL (1982 to January 2006), CINAHL (1982 to January 2006), Science Citation Index (1992 to March 2005) and registers of ongoing trials. We also checked the reference lists of all relevant articles and reviews, and contacted researchers in the field. SELECTION CRITERIA: Randomized unconfounded trials comparing amphetamine with placebo. DATA COLLECTION AND ANALYSIS: Two review

Cochrane2007

16. Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD

Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD | Evidence-Based Mental Health This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Article Text Therapeutics Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children

Evidence-Based Mental Health2006

17. Amphetamines for schizophrenia.

Amphetamines for schizophrenia. BACKGROUND: It is estimated that between 10% and 65% of people with schizophrenia use illicit drugs such as amphetamines. This group have an increased rate of hospitalisation, homelessness, unemployment and suicide compared with those with schizophrenia who do not abuse drugs. OBJECTIVES: To evaluate the effects of amphetamines for people with schizophrenia in terms of clinically meaningful outcomes, cognitive functioning and physiological tests. SEARCH STRATEGY (...) : We searched the Cochrane Schizophrenia Group's Register (February 2002). SELECTION CRITERIA: We included all randomised controlled trials investigating the effects of amphetamines on people with schizophrenia, compared with a placebo intervention. DATA COLLECTION AND ANALYSIS: Working independently, we selected and critically appraised studies, extracted data and analysed on an intention-to-treat basis. Where possible and appropriate we calculated risk ratios (RR) and their 95% confidence

Cochrane2004

18. mixed amphetamine salts

mixed amphetamine salts CEDAC FINAL RECOMMENDATION on RECONSIDERATION and REASONS for RECOMMENDATION MIXED AMPHETAMINE SALTS EXTENDED RELEASE CAPSULES (Adderall XR™ – Shire BioChem Inc) Description: Adderall XR™ is an extended-release capsule containing d- and l-isomers of mixed amphetamine salts. The capsule contains two types of pellets in a 1:1 ratio, an immediate release pellet and a delayed release enteric coated form. Adderall XR™ is indicated for the treatment (...) of attention deficit hyperactivity disorder (ADHD). Recommendation: The Canadian Expert Drug Advisory Committee recommends that mixed amphetamine salts extended release capsules not be listed. Reasons for the Recommendation: 1. No head-to-head randomized controlled trials are available that compare mixed amphetamine salts extended release capsules with stimulants licensed in Canada – i.e. regular and sustained release formulations of methylphenidate, and dextroamphetamine. Therefore, the relative efficacy of mixed amphetamine salts

Canadian Agency for Drugs and Technologies in Health - Common Drug Review2004

19. Treatment for amphetamine withdrawal.

Treatment for amphetamine withdrawal. BACKGROUND: Amphetamine withdrawal has been less studied although it is a common problem with a prevalent rate of 87% among amphetamine users. Its symptoms, in particular intense craving, may be a critical factor leading to relapse of amphetamine use. In clinical practice, treatment for cocaine withdrawal has been recommended for the management of amphetamine withdrawal although the pharmacodynamic and pharmacokinetic properties of these two substances (...) are not the same. OBJECTIVES: To search and determine risks, benefits, and costs of a variety of treatments for the management of amphetamine withdrawal. SEARCH STRATEGY: Electronic searches of MEDLINE (1966 - December 2000), EMBASE (1980 - February 2001), CINAHL (1982 - January 2001) and Cochrane Controlled Trials Register (Cochrane Library 2000 issue 4) were undertaken. References to the articles obtained by any means were searched. SELECTION CRITERIA: All relevant randomised controlled trials (RCTs

Cochrane2001

20. Treatment for amphetamine dependence and abuse.

Treatment for amphetamine dependence and abuse. BACKGROUND: The ease of synthesis from inexpensive and readily available chemicals makes possible the wide spread of amphetamine dependence and abuse. Amphetamine use is of concern because it causes a variety of devastating health consequences, including physical and neurological disorders due to amphetamines, amphetamine-induced mental disorders, health consequences of amphetamine use and social consequences of amphetamine use. OBJECTIVES (...) : To search and determine risks, benefits and costs of a variety treatments for amphetamine dependence or abuse. SEARCH STRATEGY: Electronic searches of MEDLINE (1966 - December 2000), EMBASE (1980 - February 2001), CINAHL (1982 - January 2001) and Cochrane Controlled Trials Register (Cochrane Library 2000 issue 4) were undertaken. References to the articles obtained by any means were searched. SELECTION CRITERIA: All relevant randomised controlled trials (RCTs) and clinical controlled trials (CCTs) were

Cochrane2001